Final Operational Milestone #6

Complete IND-enabling studies for a Phase 1 study for immune dysregulation polyendocrinopathy entropathy X-linked ( IPEX) syndrome with Lentivirus transduced autologous T cells.

Team has successfully completed IND-enabling studies and FDA approval to proceed to a Phase 1 clinical trial.